Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana M Gonzalez-Angulo

Showing results (111-120 of 144) with videos related to

Pageof 15
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2009
Androgen receptor levels and association with PIK3CA mutations and prognosis in breast cancerAna M Gonzalez-Angulo, Katherine Stemke-Hale, Shana L Palla, et al.
Cancer|July 25, 2006
The safety of breast-conserving surgery in patients who achieve a complete pathologic response after neoadjuvant chemotherapyFlorentia Peintinger, W Fraser Symmans, Ana M Gonzalez-Angulo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2013
Weekly nab-Rapamycin in patients with advanced nonhematologic malignancies: final results of a phase I trialAna M Gonzalez-Angulo, Funda Meric-Bernstam, Sant Chawla, et al.
Cancer|June 28, 2012
Frequency of mesenchymal-epithelial transition factor gene (MET) and the catalytic subunit of phosphoinositide-3-kinase (PIK3CA) copy number elevation and correlation with outcome in patients with early stage breast cancerAna M Gonzalez-Angulo, Huiqin Chen, Meghan S Karuturi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2011
Validation of a novel staging system for disease-specific survival in patients with breast cancer treated with neoadjuvant chemotherapyElizabeth A Mittendorf, Jacqueline S Jeruss, Susan L Tucker, et al.
Clinical Breast Cancer|April 28, 2015
Phase II Randomized Study of Ixabepilone Versus Observation in Patients With Significant Residual Disease After Neoadjuvant Systemic Therapy for HER2-Negative Breast CancerAna M Gonzalez-Angulo, Xiudong Lei, Richardo H Alvarez, et al.
Annals of Surgery|January 8, 2013
Impact of chemotherapy sequencing on local-regional failure risk in breast cancer patients undergoing breast-conserving therapyElizabeth A Mittendorf, Thomas A Buchholz, Susan L Tucker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2014
Outcomes by tumor subtype and treatment pattern in women with small, node-negative breast cancer: a multi-institutional studyInes Vaz-Luis, Rebecca A Ottesen, Melissa E Hughes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2012
Phase III trial evaluating weekly paclitaxel versus docetaxel in combination with capecitabine in operable breast cancerCatherine M Kelly, Marjorie C Green, Kristine Broglio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2005
Factors predictive of distant metastases in patients with breast cancer who have a pathologic complete response after neoadjuvant chemotherapyAna M Gonzalez-Angulo, Sean E McGuire, Thomas A Buchholz, et al.
Pageof 15

Showing results (111-120 of 144) with videos related to

Sort By:
Pageof 15
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2009
Androgen receptor levels and association with PIK3CA mutations and prognosis in breast cancerAna M Gonzalez-Angulo, Katherine Stemke-Hale, Shana L Palla, et al.
Cancer|July 25, 2006
The safety of breast-conserving surgery in patients who achieve a complete pathologic response after neoadjuvant chemotherapyFlorentia Peintinger, W Fraser Symmans, Ana M Gonzalez-Angulo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2013
Weekly nab-Rapamycin in patients with advanced nonhematologic malignancies: final results of a phase I trialAna M Gonzalez-Angulo, Funda Meric-Bernstam, Sant Chawla, et al.
Cancer|June 28, 2012
Frequency of mesenchymal-epithelial transition factor gene (MET) and the catalytic subunit of phosphoinositide-3-kinase (PIK3CA) copy number elevation and correlation with outcome in patients with early stage breast cancerAna M Gonzalez-Angulo, Huiqin Chen, Meghan S Karuturi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2011
Validation of a novel staging system for disease-specific survival in patients with breast cancer treated with neoadjuvant chemotherapyElizabeth A Mittendorf, Jacqueline S Jeruss, Susan L Tucker, et al.
Clinical Breast Cancer|April 28, 2015
Phase II Randomized Study of Ixabepilone Versus Observation in Patients With Significant Residual Disease After Neoadjuvant Systemic Therapy for HER2-Negative Breast CancerAna M Gonzalez-Angulo, Xiudong Lei, Richardo H Alvarez, et al.
Annals of Surgery|January 8, 2013
Impact of chemotherapy sequencing on local-regional failure risk in breast cancer patients undergoing breast-conserving therapyElizabeth A Mittendorf, Thomas A Buchholz, Susan L Tucker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2014
Outcomes by tumor subtype and treatment pattern in women with small, node-negative breast cancer: a multi-institutional studyInes Vaz-Luis, Rebecca A Ottesen, Melissa E Hughes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2012
Phase III trial evaluating weekly paclitaxel versus docetaxel in combination with capecitabine in operable breast cancerCatherine M Kelly, Marjorie C Green, Kristine Broglio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2005
Factors predictive of distant metastases in patients with breast cancer who have a pathologic complete response after neoadjuvant chemotherapyAna M Gonzalez-Angulo, Sean E McGuire, Thomas A Buchholz, et al.
Pageof 15